Shares of Herborium Group Inc. (PINK: HBRM), a botanical therapeutics company engaged in the development, licensing and marketing of botanical-based medicinal products targeting unmet medical needs, have risen sharply today after the company announced continuing progress in key strategic initiatives.
HBRM shares are currently trading 25.42% higher at $0.0074 on volume of 34.03 million.
Herborium, today, said that it is progressing through the negotiating phase with China Health Resource Inc. regarding a potential acquisition.
HBRM noted that the partnership with Kamasutra LLC has moved into the introductory marketing phase with the digital marketing plan to be initiated in June this year.
Dr. Agnes P. Olszewski, CEO of Herborium, meanwhile, recently completed the National Publicity Summit in New York City. The company expects multiple media exposure opportunities resulting from the Summit.
Recent Comments